Back
Intensity Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
16
INTS
Intensity Therapeutics
Last Price:
$0.33
Seasonality Move:
-27.87%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and INTS is experiencing slight buying pressure.
Intensity Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.32 | Buy |
| 20-day SMA: | 0.31 | Buy |
| 50-day SMA: | 0.39 | Sell |
| 200-day SMA: | 1.92 | Sell |
| 8-day EMA: | 0.27 | Buy |
| 20-day EMA: | 0.16 | Buy |
| 50-day EMA: | 0.08 | Buy |
| 200-day EMA: | 0.02 | Buy |
Intensity Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 42.98 | Sell |
| Chaikin Money Flow: | -293860 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.26 - 0.4) | Sell |
| Bollinger Bands (100): | (0.3 - 1.96) | Sell |
Intensity Therapeutics Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intensity Therapeutics Stock
Is Intensity Therapeutics Stock a Buy?
-
Intensity Therapeutics share price is 0.33 while INTS 8-day simple moving average is 0.32, which is a Buy signal.
-
The stock price of INTS is 0.33 while Intensity Therapeutics 20-day SMA is 0.31, which makes it a Buy.
-
Intensity Therapeutics 50-day simple moving average is 0.39 while INTS share price is 0.33, making it a Sell technically.
-
INTS stock price is 0.33 and Intensity Therapeutics 200-day simple moving average is 1.92, creating a Sell signal.
INTS Technical Analysis vs Fundamental Analysis
Sell
16
Intensity Therapeutics (INTS)
is a Sell
Is Intensity Therapeutics a Buy or a Sell?
-
Intensity Therapeutics stock is rated a SellThe current Intensity Therapeutics [INTS] share price is $0.33. The Score for INTS is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
Intensity Therapeutics Stock Info
Market Cap:
6M
Price in USD:
0.33
Share Volume:
2.5M
Intensity Therapeutics 52-Week Range
52-Week High:
5.01
52-Week Low:
0.26
Sell
16
Intensity Therapeutics (INTS)
is a Sell
Intensity Therapeutics Share Price Forecast
-
What is the Intensity Therapeutics stock price today?The Intensity Therapeutics stock price is 0.33 USD today.
-
Will INTS stock go up or go down?Intensity Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Intensity Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intensity Therapeutics is overvalued.
Is Intensity Therapeutics Stock a Buy?
-
Intensity Therapeutics share price is 0.33 while INTS 8-day exponential moving average is 0.27, which is a Buy signal.
-
The stock price of INTS is 0.33 while Intensity Therapeutics 20-day EMA is 0.16, which makes it a Buy.
-
Intensity Therapeutics 50-day exponential moving average is 0.08 while INTS share price is 0.33, making it a Buy technically.
-
INTS stock price is 0.33 and Intensity Therapeutics 200-day simple moving average is 0.02, creating a Buy signal.
Fundamental Analysis of Intensity Therapeutics
Is Intensity Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.23 per share.
Technical Analysis of Intensity Therapeutics
Should I short Intensity Therapeutics stock?
-
INTS Moving Average Covergence Divergence (MACD) indicator is 0.09, suggesting Intensity Therapeutics is a Buy
-
Intensity Therapeutics Relative Strength Index (RSI) is 42.98, which suggest Intensity Therapeutics is oversold
-
The Bollinger Bands (25) for Intensity Therapeutics is (0.26 - 0.4), which suggest Intensity Therapeutics is a Sell
-
The Bollinger Bands (100) for Intensity Therapeutics is (0.3 - 1.96), which suggest Intensity Therapeutics is a Sell
* Intensity Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.